Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Documentation
Home
>
Investors & media
>
Documentation
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
Documentation type
All
General Assembly
Financial statements and reports
Regulated information
Corporate presentations
General meetings
08 April 2021
General meetings
Shares and voting rights statement – 2021 General Meeting
Open in new window
08 April 2021
General meetings
Proxy card – 2021 General Meeting
Open in new window
08 April 2021
General meetings
Notice of General Meeting on April 29, 2021
Open in new window
08 April 2021
General meetings
BALO prior notification – 2021 General Meeting
Open in new window
08 April 2021
Financial statements and reports, General meetings
2020 Universal Registration Document
Open in new window
22 October 2020
Regulated information
Securities Note
Open in new window
22 October 2020
Financial statements and reports, Regulated information
Amendment to the 2019 Universal Registration Document
Open in new window
30 July 2020
Financial statements and reports
2020 Half-Year Financial Report
Open in new window
30 April 2020
General meetings
Compensation policy of the Board members
Open in new window
30 April 2020
General meetings
Compensation policy of the Chief Executive Officer and / or any other Corporate Officer
Open in new window
View previous 9 articles
1
…
7
8
9
10
11
12
13
14
15
16
17
…
21
View next 9 articles
Go back to the page of the page